<html>
<head>PUBMED IDs for IP3R3</head>
<body bgcolor='#C5F0F2'><h1>IP3R3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/14619519/'>[Possible involvement of inositol 1, 4, 5-trisphosphate receptor type 3 (IP3R3) in the peritoneal dissemination of gastric cancers].</a> November 19  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14666665/'>Possible involvement of inositol 1,4,5-trisphosphate receptor type 3 (IP3R3) in the peritoneal dissemination of gastric cancers.</a> December 12  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14666661/'>c-IAP1 is overexpressed in HL-60 cells selected for doxorubicin resistance: effects on etoposide-induced apoptosis.</a> December 12  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/16006774/'>Inositol 1,4,5-trisphosphate receptor phosphorylation in breast cancer.</a> July 12  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16006757/'>The absence of immunoreactivity for tissue inhibitor of metalloproteinase-1 (TIMP-1), but not for TIMP-2, protein is associated with a favorable prognosis in aggressive breast carcinoma.</a> July 12  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16960798/'>Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden.</a> September 9  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/24642269/'>Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival.</a> September 26  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26119739/'>Microtubule-Associated Protein EB3 Regulates IP3 Receptor Clustering and Ca(2+) Signaling in Endothelial Cells.</a> April 9  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27098757/'>Coupling switch of P2Y-IP3 receptors mediates differential Ca(2+) signaling in human embryonic stem cells and derived cardiovascular progenitor cells.</a> April 22  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28614305/'>BAP1 regulates IP3R3-mediated Ca(2+) flux to mitochondria suppressing cell transformation.</a> June 15  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28614300/'>PTEN counteracts FBXL2 to promote IP3R3- and Ca(2+)-mediated apoptosis limiting tumour growth.</a> June 15  2017<br></body></html>
